Dexcom wins CMS nod for latest glucose monitor

Dexcom (NSDQ:DXCM) said today that its G6 continuous glucose monitoring system will be covered for Medicare beneficiaries.
The company’s product won coverage as a therapeutic CGM system, making it available to beneficiaries who closely manage their insulin dosing.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom wins CMS nod for latest glucose monitor appeared first on MassDevice.

Source: Mass Device - October 18, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Featured Patient Monitoring Weight loss Dexcom Source Type: news